Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, presented highlights of Phase 1 clinical data for RN0361, a long-acting Apolipoprotein C3 (ApoC3) siRNA. RN0361 ...

Whether Hif-1α and 2α are responsible for hypoxia and IL-1β-induction was determined by culturing the transfected and non-transfected chondrocytes under hypoxic conditions and IL-1β induction. The ...

Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB ...

REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, ...

Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)King of Prussia, Pennsylvania ...

RNA interference using small interfering RNAs (siRNAs) has become a mainstay of functional gene characterization and has ...

Findings provide scientific insights into the contribution of small interfering RNA (siRNA) and therapeutic vaccination towards the HBV functional cure strategy DURHAM, N.C. and BEIJING, Nov. 7, 2025 ...

The current coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has challenged healthcare facilities globally. Even though the FDA ...

Researchers found a modified peptide carrier that was delivering the siRNA drug by adhering to and potentially moving along cell filopodia, leading to more efficient cell entry and improved gene ...

From our June 15 issue: Treatments based on RNA interference are improving now that technologies are delivering longer-lasting gene silencing. The 2006 Nobel Prize in Physiology or Medicine was ...

Hayyuun aantiroopolojii lammii Eertiraa piroofeesar Asmaroom Laggasaa waggoota 45 oliif sirna Gadaa qorataniiru. Qorannoo isaanii kanas kitaabota lamaan maxxansiisanii Sirna Gadaa addunyaa waliin wal ...